Skip to main content
Whitepaper

COVID-19 therapeutics: demand, challenges, and the future

engineered-viral-hero

In a lively panel discussion, Dr. Kevin Coombs, Dr. Randal Ketchem, Dr. Mansoor Amiji, and Dr. Seyoum Ayehunie provided insights into why developing effective COVID-19 treatments plays a significant role in controlling panemdics. They also explored the therapeutic approaches pursued by the research community, and the hurdles scientists face when trying to bring such a treatment to the clinic. This whitepaper highlights the key discussion points addressed during the session.

For research use only. Not for use in diagnostic procedures.

To view the full content please answer a few questions

By submitting my personal data, I acknowledge that Revvity Inc. and its affiliates (“Company”) will process my personal data provided above consistent with the Company’s Privacy Policy available here.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Download Resource

COVID-19 therapeutics: demand, challenges, and the future